BRIEF published on 08/12/2025 at 09:06, 1 year 1 month ago Dr. Hönle AG Maintains Positive Outlook Amid Mixed Q3 Results EBITDA Revenue Decline Q3 Results Future Prospects Dr. Hönle AG
BRIEF published on 08/12/2025 at 09:06, 1 year 1 month ago Dr. Hönle AG maintient ses perspectives positives malgré des résultats mitigés au troisième trimestre EBITDA Baisse Des Revenus Perspectives D'avenir Résultats Du Troisième Trimestre Dr. Hönle AG
PRESS RELEASE published on 08/12/2025 at 09:01, 1 year 1 month ago Original-Research: Dr. Hönle AG (von NuWays AG): BUY Dr. Hönle AG reports mixed Q3 results with lower FY guidance. Operations impacted by weak demand in key markets, especially adhesives. Focus on stabilization and cost reductions Q3 Results Stabilization Dr. Hönle AG Lower Guidance Adhesives
Published on 09/12/2026 at 02:35, 11 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 35 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 30 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 10 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 35 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 5 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 20 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 25 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 17 hours 50 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 20 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
